Disease Info Card

Moyamoya Disease

Information about Moyamoya Disease: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Moyamoya Disease

Most recent studies have shown that Moyamoya Disease shares some biological mechanisms with aneurysm, arterial-occlusive-diseases, brain-ischemia, carotid-stenosis, cerebral-hemorrhage, cerebral-infarction, cerebral-ischemia, cerebrovascular-accident, cerebrovascular-disorders, headache, hemiparesis, hemorrhage, infarction, intracranial-aneurysm, ischemia, stenosis, subarachnoid-hemorrhage, transient-ischemic-attack.

Among the many pathways, these few ones have gauged particular interests from scientists studying Moyamoya Disease, and have been seen in publications frequently: Aging, Angiogenesis, Blood Circulation, Cell Growth, Cell Migration, Cell Proliferation, Coagulation, Cognition, Fibrinolysis, Localization, Muscle Cell Proliferation, Pathogenesis, Platelet Aggregation, Secretion, Smooth Muscle Cell Proliferation, Transposition, Vasculogenesis, Vasoconstriction, Vasodilation, Wound Healing

Quite a number of genes have been found to play important roles in Moyamoya Disease, such as ACTA2, ADAMTS13, BRAP, CSF2, EMD, FGF2, FLVCR1, ICA, IMPA1, LAMC2, MMD, NF1, NLRP5, RNF213, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.

Moyamoya Disease Related Genes

click to see detail information for each gene

ACTA2 ADAMTS13 BRAP
CSF2 EMD FGF2
FLVCR1 ICA IMPA1
LAMC2 MMD NF1
NLRP5 RNF213 VEGFA